NCT01282151 - TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer | Biotech Hunter

Enrollment

148

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2014

Conditions

Carcinoma, Non Small Cell Lung

Interventions

DRUG

Taxotere

Docetaxel 60 mg/m2 q3 weeks Cisplatin 70 mg/m2 q3 weeks

DRUG

Pemetrexed

Pemetrexed 500 mg/m2 q3 weeks Cisplatin 70 mg/m2 q3 weeks

Trial Locations (15)

Chonnam National University Hwasun Hospital, Hwasun

Kyungpook National University Medical Center, Daegu

Hallym University Medical Center, Anyang

Yeungnam Univeristy Hospital, Daegu

Chosun University Hospital, Gwangju

Wonkwang University Hospital, Iksan

Inha University Hospital, Incheon

Kosin University Gospel Hospital, Pusan

Korea Cancer Center Hospital, Seoul

Korea University Medical Center, Seoul

Wonju Christian Hospital, Wŏnju

Dankook University Hospital, Cheonan

Keimyung University Dongsan Center, Daegu

Pusan National University Hospital, Pusan

Konkuk university medical center, Seoul